510(k) Report

510(k) · Cleared

Cleared

ABL90 Flex, ABL90 Flex Plus

K170882510(k) TraditionalCleared Apr 28, 201735-day reviewClass I21 CFR 862.1113

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Radiometer Medical Aps · MQM Bilirubin (Total And Unbound) In The Neonate Test System

Cleared on Apr 28, 2017 as substantially equivalent to K050869 (Radiometer Medical Aps, 2005) after a 35-day review. Its family tree reaches back 6 generations to 1986.

Decided
Apr 28, 2017
Review
35 days
Class
Class I
Product code
MQM
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K861087 (1986). 17 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 6 generations backK861087 Avl Model 983 Electrolyte AnalyzerAvl Scientific Corp. · 1986
  2. 5 generations backK961458 Avl 9180 Electrolyte AnalyzerAvl Scientific Corp. · 1996 · Recalled
  3. 4 generations backK972673 Avl 9181 Electrolyte AnalyzerAvl Scientific Corp. · 1997 · Recalled
  4. 3 generations backK992859 ABL700 Series Analyzer with Autocheck ModuleRadiometer America, Inc. · 2000 · Recalled
  5. 2 generations backK041874 ABL800 FlexRadiometer Medical Aps · 2004 · Recalled
  6. 1 generation backK050869 Modification to ABL800 FlexRadiometer Medical Aps · 2005 · Recalled
  7. This deviceK170882 ABL90 Flex, ABL90 Flex PlusRadiometer Medical Aps · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K861087Avl Model 983 Electrolyte AnalyzerAvl Scientific Corp.1986—
−5K961458Avl 9180 Electrolyte AnalyzerAvl Scientific Corp.19961
−4K972673Avl 9181 Electrolyte AnalyzerAvl Scientific Corp.19977
−3K992859ABL700 Series Analyzer with Autocheck ModuleRadiometer America, Inc.20004
−2K041874ABL800 FlexRadiometer Medical Aps200422
−1K050869Modification to ABL800 FlexRadiometer Medical Aps20051
0 (this device)K170882ABL90 Flex, ABL90 Flex PlusRadiometer Medical Aps2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198610
198710
199210
199510
199630
199710
199820
200010
FIG. 1 — Lineage of K170882, 1986–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K050869Modification to ABL800 Flex
Summary page 7
…blood is substantially equivalent in Intended Use, fundamental scientific technology, features, and characteristics to the predicate: 510(k) Number/Device Manufacturer: K050869 ABL800 FLEX, Radiometer Medical ApS Similarities Item…
Radiometer Medical Aps20051

Also cleared against K050869: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 31 years and passes through 3 companies; a new generation was cleared every 4.7 years on median.
  • 10 of the 17 ancestors have a recall of any class.
  • 3 other devices also cite its predicate K050869.

How does its category compare?

All MQM devices

MQM Bilirubin (Total And Unbound) In The Neonate Test System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · MQM

1in 2017

2008: 12011: 12014: 22017: 1
2007high 2 (2014) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQM

Too few MQM 510(k)s in any year since 2007 to give a median.

Recalls per year · MQM

No recall names MQM since 2007.

Adverse event reports per year · MQM

2in 2025

2007: 52008: 32010: 42011: 32012: 42014: 12015: 12016: 12017: 12018: 52019: 62020: 12021: 12023: 142024: 172025: 2
2007high 17 (2024) · low 0 (2009)2025

MAUDE reports naming product code MQM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—05
20081—03
20090—00
20100—04
20111—03
20120—04
20130—00
20142—01
20150—01
20160—01
20171—01
20180—05
20190—06
20200—01
20210—01
20220—00
20230—014
20240—017
20250—02
20260—0—

What is it indicated for?

ABL90 FLEX: The ABL90 FLEX analyzer is an in vitro diagnostic, portable, automated analyzer that quantitatively measures neonatal bilirubin in heparinized capillary, venous and arterial whole blood. The ABL90 FLEX analyzer is intended for use by trained technologists, nurses, physicians and therapists. It is intended for use in a laboratory environment, near patient or point-of-care setting. These tests are only performed under a physician's order.…

Read the full statement (172 words)

ABL90 FLEX:

The ABL90 FLEX analyzer is an in vitro diagnostic, portable, automated analyzer that quantitatively measures neonatal bilirubin in heparinized capillary, venous and arterial whole blood.

The ABL90 FLEX analyzer is intended for use by trained technologists, nurses, physicians and therapists.

It is intended for use in a laboratory environment, near patient or point-of-care setting.

These tests are only performed under a physician's order.

Bilirubin measurements on the ABL90 FLEX analyzer are intended to aid in assessing the risk of kernicterus in neonates.

ABL90 FLEX PLUS:

The ABL90 FLEX PLUS analyzer is an in vitro diagnostic, portable, automated analyzer that quantitatively measures neonatal bilirubin in heparinized capillary, venous and arterial whole blood.

The ABL90 FLEX PLUS analyzer is intended for use by trained technologists, nurses, physicians and therapists.

It is intended for use in a laboratory environment, near patient or point-of-care setting.

These tests are only performed under a physician's order.

Bilirubin measurements on the ABL90 FLEX PLUS analyzer are intended to aid in assessing the risk of kernicterus in neonates.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K170882: ABL90 Flex, ABL90 Flex Plus.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K170882

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026